NSF International President and CEO Kevan Lawlor speaks at a recent pharmaceutical industry event in Hamburg, Germany. NSF International has acquired a majority interest in Amarex Clinical Research, LLC, a clinical stage contract research organization (CRO) headquartered in Germantown, Maryland.
NSF International President and CEO Kevan Lawlor speaks at a recent pharmaceutical industry event in Hamburg, Germany. NSF International has acquired a majority interest in Amarex Clinical Research, LLC, a clinical stage contract research organization (CRO) headquartered in Germantown, Maryland.